Latest Ketones Stories
Body chemistry analysis, diagnosis, and treatment now available to more patients through an expanded network of doctors, now also subsidized by many insurance programs FOSTER CITY,
Helping eligible opioid dependent patients in need MORRISTOWN, N.J., Oct. 7, 2014 /PRNewswire/ -- As part of our ongoing commitment to addiction medicine, Orexo US, Inc.
CAMBRIDGE, England, October 7, 2014 /PRNewswire/ -- Acacia Pharma announces positive Phase 3 results with APD421 for the management of post-operative nausea & vomiting
The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered life-threatening internal bleeding, deep vein thrombosis, pulmonary embolism, and other serious complications, allegedly
Conference Call Scheduled for Tuesday, October 7 at 8:00 AM Eastern Time RALEIGH, N.C., Oct. 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc.
New white paper released as hydrocodone is reclassified as a Schedule II drug ITASCA, Ill., Oct.
LONDON, Oct. 2, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc.
According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain.
JOHNSTOWN, Pa., Sept.
ST. PAUL, Minn., Sept. 30, 2014 /PRNewswire/ -- In 2011, approximately 5.1 million people in the United States abused prescription pain relievers (e.g.
- totally perplexed and mixed up.
More Images (1 images) »